The document discusses the drug carbetocin, including its mechanism of action, indications, contraindications, adverse effects, dosage, and nursing responsibilities. Carbetocin is a synthetic analogue of oxytocin used to prevent uterine atony and postpartum hemorrhage following childbirth. It works by selectively binding to oxytocin receptors in the uterine smooth muscle. Nurses are responsible for monitoring vital signs and the strength and frequency of uterine contractions in patients receiving the drug.
The document discusses the drug carbetocin, including its mechanism of action, indications, contraindications, adverse effects, dosage, and nursing responsibilities. Carbetocin is a synthetic analogue of oxytocin used to prevent uterine atony and postpartum hemorrhage following childbirth. It works by selectively binding to oxytocin receptors in the uterine smooth muscle. Nurses are responsible for monitoring vital signs and the strength and frequency of uterine contractions in patients receiving the drug.
The document discusses the drug carbetocin, including its mechanism of action, indications, contraindications, adverse effects, dosage, and nursing responsibilities. Carbetocin is a synthetic analogue of oxytocin used to prevent uterine atony and postpartum hemorrhage following childbirth. It works by selectively binding to oxytocin receptors in the uterine smooth muscle. Nurses are responsible for monitoring vital signs and the strength and frequency of uterine contractions in patients receiving the drug.
The document discusses the drug carbetocin, including its mechanism of action, indications, contraindications, adverse effects, dosage, and nursing responsibilities. Carbetocin is a synthetic analogue of oxytocin used to prevent uterine atony and postpartum hemorrhage following childbirth. It works by selectively binding to oxytocin receptors in the uterine smooth muscle. Nurses are responsible for monitoring vital signs and the strength and frequency of uterine contractions in patients receiving the drug.
659-A Cecilia Muñoz St, Ermita, Manila, 1000 Metro Manila
Name: EIRENE A. GAPATE Clinical Instructor: PROF. XENIA MICHELLE M. ARCILLA
Group No.: 1A Date: JULY 28, 2023 Yr/Level: LEVEL III Area: OB WARD
DRUG STUDY: CARBETOCIN
DRUG MECHANISM INDICATION CONTRAINDICATIONS ADVERSE EFFECTS NURSING RESPONSIBILITIES
OF ACTION Generic Name: Carbetocin is a Prevention of uterine atony Patients with a history of Significant: May produce Nursing Responsibilities: Carbetocin synthetic analogue of and postpartum hemorrhage hypersensitivity to oxytocin or antidiuretic effect, which 1. Start flow charts to record maternal BP and oxytocin with a following elective caesarian carbetocin; vascular disease, may lead to the risk of other vital signs, I&O ratio, weight, strength, Brand Name: longer duration of section under epidural or especially coronary artery hyponatraemia or water duration, and frequency of contractions, before Duratocin activity. It selectively spinal anesthesia. disease, except extreme intoxication. instituting treatment. binds to oxytocin caution; renal or hepatic Blood and lymphatic 2. Check fundus frequently during the first few Classification: receptors in the Method of administration: disease. system: Anaemia. postpartum hours and several times daily Uteronic/oxytocic uterine smooth For intravenous or Cardiovascular: thereafter. agent. muscle, resulting in intramuscular Use in pregnancy: Tachycardia. Carbetocin belongs to rhythmic contractions administration: Prophylaxis Because of its long duration of Gastrointestinal: Nursing Considerations: the class of oxytocin of the uterus, of postpartum haemorrhage action relative to oxytocin, Abdominal pain, nausea, 1. Repeat administration is not recommended if and analogues. increasing the due to uterine atony after uterine contractions produced vomiting, metallic taste. uterine contraction post delivery is not adequate. fequency of existing vaginal delivery. by carbetocin cannot be General and administration 2. Caution if used in women with eclampsia or Dosage: contractions, and Carbetocin 100 mcg must stopped by simply site conditions: Feeling of pre-eclampsia as BP should be closely monitored. Single dose, uterine tone. The only be administered after discontinuing the medication. warmth, chills, pain, 3. Not recommended in emergency post delivery 100mcg/ml oxytocin receptor delivery of the infant, as a Therefore, carbetocin should pyrexia. via CS or caginal delivery. content of the uterus single dose and as soon as not be administered prior to Musculoskeletal and Frequency: is very low in the possible after delivery, delivery of the infant for any connective tissue: Back Slow IV injection non-pregnant state, preferably before the reason, including elective or pain, muscular weakness. over 1 minute and increases during delivery of the placenta medical induction of labour. Nervous system: pregnancy, reaching a Inappropriate use of Headache, tremor, Form: peak at the time of For Intravenous: carbetocin during pregnancy dizziness. Injection delivery. Prophylaxis of uterine could theoretically mimic the Respiratory: Chest pain, Additionally, it atony and excessive symptoms of overdose, dyspnoea. enhances uterine bleeding after caesarean including hyperstimulation of Skin and subcutaneous involution early in section. Preferably under the uterus with strong tissue: Pruritus, postpartum. epidural or spinal (hypertonic) or prolonged diaphoresis. anesthesia: 100 mcg as a (tetanic) contractions, Vascular: Hypotension, single dose via bolus tumultuos labour, uterine flushing. injection slowly over 1 rupture, cervical and vaginal minute, given after delivery lacerations, postpartum of infant preferrably before hmorrhage, uteroplacental removal of placenta. hypoperfusion and variable deceleration of fetal heart, fetal hypoxia, hypercapnia or death.
